CClinicalTrials.gg
Enrolling by invitationNCT06989281Updated May 22, 2026

Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB

An interventional study of FLOW Lifestyle Medicine Clinic in Obesity and Obesity-related Medical Conditions, sponsored by University of Alabama at Birmingham. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

This is a randomized quality improvement project (i.e., not a research study) that will test the implementation and effectiveness of a lifestyle medicine clinic at the University of Alabama at Birmingham.

Read the detailed description

This is a randomized quality improvement project that has received a non-human subjects research determination from the IRB at the University of Alabama at Birmingham. This study will use a randomized encouragement trial design to test whether a lifestyle medicine clinic at UAB (FLOW: Fitness, Lifestyle, and Optimum Wellness) is implementable and effective for improving cardiometabolic health (e.g., body weight, body composition, blood pressure, blood glucose, and blood lipids). Only patients of the UAB Family and Community Clinic are included in this project (i.e., no outside recruitment/enrollment).

02

Conditions studied

  • Obesity and Obesity-related Medical Conditions

Browse trials for

Keywords

  • Quality Improvement Project
  • Implementation
  • Clinical Effectiveness
  • Encouragement Design
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Current patient of the UAB Family \& Community Medicine Clinic or UAB Rheumatology Clinic
  • BMI: greater than or equal to 25 kg/m2
  • Previous diagnosis of at least one of the following conditions:
  • prediabetes or type 2 diabetes
  • prehypertension or hypertension
  • dyslipidemia
  • psoriatic arthritis

Exclusion criteria

Exclusion Criteria:

  • Not a current patient of the UAB Family \& Community Medicine Clinic or UAB Rheumatology Clinic
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Encouraged to Enroll in FLOW

    Patients randomized to this condition receive extra encouragement to consider enrolling in the FLOW lifestyle medicine clinic. This encouragement includes the addition of 2 questions added to their patients' pre-visit intake process regarding their interest in making healthy lifestyle changes to improve their cardiometabolic health. If affirmative, the Certified Medical Assistant will provide the patient with a FLOW brochure and make a note for the provider to follow-up with the patient and consider referral to the FLOW clinic.

    Behavioral: FLOW Lifestyle Medicine Clinic

  • Active comparator
    Not Encouraged to Enroll in FLOW

    Patients randomized to this condition do not receive extra encouragement to enroll in the FLOW lifestyle medicine clinic. They are still able to access to the FLOW clinic via brochures placed in the waiting area and exam rooms or direct referral by their healthcare provider (without having been "encouraged.")

    Behavioral: FLOW Lifestyle Medicine Clinic

Interventions

  • BehavioralFLOW Lifestyle Medicine Clinic

    The FLOW Lifestyle Medicine Clinic is a 12-month multidisciplinary program for improving obesity and obesity-related chronic conditions. FLOW is an evidence-based program that aligns with USPSTF recommendations for intensive behavioral counseling for obesity and cardiovascular disease risk reduction. There are at least 12 clinician/patient encounters in the FLOW clinic over 12 months including 6 with a registered dietitian and 6 with a FLOW physician. Behavioral Health assessments and visits are also offered as part of FLOW but are optional.

06

What researchers measure

Primary outcomes

  1. Rate of Referral

    Comparison of rates of referral to the FLOW clinic between the Encouraged and Not Encouraged conditions.

    Time frame: Baseline

  2. Rate of Enrollment

    Comparison of rates of enrollment in the FLOW clinic between the Encouraged and Not Encouraged conditions.

    Time frame: Baseline

Secondary outcomes

  1. ITT Estimand, Change in Body Weight

    A comparison body weight changes occurring over 12 months between patients assigned to Encouraged vs. Not Encouraged.

    Time frame: Baseline and 12 months

  2. ITT Estimand, Change in Composite Cardiometabolic Health

    A comparison of changes in cardiometabolic health occurring over 12 months between patients assigned to Encouraged vs. Not Encouraged. The composite score is derived from values for body weight, percentage body fat, blood pressure, clinical labs, fitness tests, and questionnaires.

    Time frame: Baseline to Month 12

  3. Complier Average Causal Effect, Change in Body Weight

    A comparison body weight changes occurring over 12 months between patients who enrolled vs. did not enroll in FLOW regardless of whether they were assigned to Encouraged or Not Encouraged.

    Time frame: Baseline and 12 months

  4. Complier Average Causal Effect, Change in Composite Cardiometabolic Health

    A comparison changes in cardiometabolic health occurring over 12 months between patients who enrolled vs. did not enroll in FLOW regardless of whether they were assigned to Encouraged or Not Encouraged. The composite score is derived from values for body weight, percentage body fat, blood pressure, clinical labs, fitness tests, and questionnaires.

    Time frame: Baseline to Month 12

07

Study locations

1 site
  • University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
08

References and documents

Individual participant data

Plan to share: No — This project is a quality improvement project intended for improving obesity and obesity related cardiometabolic health among UAB patients. Because this project is not "research" (i.e., contributing to generalizable knowledge), we do not believe it is appropriate to share IDP with outside investigators.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06989281
Lead sponsor
University of Alabama at Birmingham
Collaborators
Eli Lilly and Company
Responsible party
Drew Sayer (Assistant Professor, University of Alabama at Birmingham) — Principal investigator
First posted
May 25, 2025
Start date
May 3, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 22, 2026

Study contacts

Drew Sayer, PhD
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion